OLYMPUS Corp/S (OCPNY) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of OLYMPUS Corp/S (OTCMKTS:OCPNY) from a hold rating to a sell rating in a report published on Wednesday.

According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “

Separately, ValuEngine upgraded shares of OLYMPUS Corp/S from a hold rating to a buy rating in a report on Wednesday, September 26th.

OTCMKTS:OCPNY opened at $27.50 on Wednesday. OLYMPUS Corp/S has a 52 week low of $26.77 and a 52 week high of $41.87. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.42 and a quick ratio of 1.01. The firm has a market cap of $9.25 billion, a P/E ratio of 18.21, a PEG ratio of 3.75 and a beta of 0.89.

OLYMPUS Corp/S Company Profile

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices.

See Also: Different Types of Derivatives

Get a free copy of the Zacks research report on OLYMPUS Corp/S (OCPNY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for OLYMPUS Corp/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OLYMPUS Corp/S and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply